Leeford

What Leeford does

Leeford Healthcare Limited is a privately held Indian pharmaceutical manufacturer founded in 2006 and headquartered in Ludhiana, Punjab, with a corporate office in Mumbai. The company operates five branded divisions: Healthcare (950+ products across 30+ therapeutic segments), Wellness (900+ products across 32 segments), Cosmacia (150+ personal care products), MediScience (specialty urology and nephrology with 15 nephrology brands and 19 urology brands), and Esencia (premium personal care and nutraceuticals). Manufacturing is WHO-GMP compliant across oral solids, liquids, parenterals, and semi-solid dosage forms, with in-house formulation & development capabilities and research into Novel Drug Delivery Systems (NDDS). Supporting infrastructure includes an orthosis plant producing orthopedic supports (knee, cervical, abdominal, lumbar devices) and an ayurvedic/herbal product line.

Leeford serves four primary customer segments horizontally: healthcare providers and patients (generic and specialty medicines), B2C consumers (personal care and wellness via the leefordonline.in D2C storefront), specialty care physicians and patients (nephrologists and urologists via MediScience and the Reno Academy clinical engagement platform), and trade partners (distributors, wholesalers, retailers through partner programs requiring Drug License and GST documentation). The go-to-market combines a traditional multi-channel pharma distribution network spanning 1800+ touchpoints across India with international exports to 10+ overseas destinations and a direct e-commerce channel.

The business model is unit-sale based (one-time product purchase) across prescription generics, OTC, ayurvedic/herbal supplements, personal care, medical devices, and orthotics. Pricing is not publicly disclosed and varies by channel and market. The company is founder-led under Managing Director Amit Gupta with 3000-5000+ employees and has been characterized by Zee Business as "India's 2nd largest healthcare giant" in segment coverage. No external funding rounds, M&A activity, or public listing have been disclosed; growth has been internally financed through division launches, plant expansions (including a 2021 orthosis expansion), and progressive internationalization.

Name

Leeford

Legal name

Leeford Healthcare Limited

Website

https://leeford.in

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Leeford Healthcare Limited is a privately held Indian pharmaceutical manufacturer founded in 2006, operating five divisions (Healthcare, Wellness, Cosmacia, MediScience, Esencia) with 2000+ products across 70+ therapeutic categories, distributed via 1800+ touchpoints domestically and exports to 10+ countries.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Health and Personal Care Retailers (456)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Endocrinology & Metabolic Specialty Pharmaceuticals (HLAIACAD), Health & Pharmacy Omnichannel (CRAFAEAK), Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)

Keywords

• Generic pharmaceuticals
• Specialty medicines
• Personal care products
• Orthopedic supports
• Wellness supplements

Headquarters

HQ city

Ludhiana

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Products: Revenue from manufacturing and selling generic pharmaceutical products across 950+ products in Healthcare division and 900+ products in Wellness division across 30+ therapeutic segments. Products sold through distribution network and direct-to-consumer online store.
2. Personal Care & Cosmetics: Cosmacia division offers 150+ personal care products with scientifically designed formulas. Esencia division provides premium innovative personal care and nutraceutical products. Revenue through online store and retail partners.
3. Specialty Pharmaceuticals: Medisciences division focuses on urology and nephrology with 15 brands in nephrology and 19 brands in urology. Specialized products for renal care.
4. Medical Devices & Orthotics: Surgical products and orthosis products including abdominal belts, knee supports, cervical collars, and other orthopedic supports.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Leeford Healthcare Limited manufactures and sells generic pharmaceuticals, specialty medicines, personal care products, and orthopedic supports through five divisions: Healthcare (950+ products across 30+ therapeutic segments), Wellness (900+ products across 32 therapeutic segments), Medisciences (specialty urology and nephrology with 34 brands), Cosmacia (150+ personal care products), and Esencia (premium personal care and nutraceuticals). The company operates WHO-GMP compliant manufacturing facilities and serves domestic and international markets through a vast distribution network and a direct-to-consumer online store.

Product overview

Leeford Healthcare Limited is a pharmaceutical company offering a diversified portfolio of healthcare products across multiple divisions. The company operates through five main divisions: Healthcare (950+ products across 30+ therapeutic segments), Wellness (900+ products across 32 segments), Cosmacia (personal care with 150+ products), Medisciences (urology and nephrology specialty with 34 brands), and Esencia (premium personal care and nutraceuticals). The product portfolio includes generic medicines, OTC products, ayurvedic supplements, personal care items, orthopedic supports, and medical devices. Products are available across various dosage forms including tablets, capsules, syrups, injectables, topical formulations, and medical devices.

Differentiator

Problem solved

Functional benefit

Brands

• Healthcare: First pharmaceutical division offering 950+ products across 30+ therapeutic segments with robust distribution network
• Wellness
• Cosmacia
• Esencia
• MediScience

Products and services

• Healthcare Division First pharmaceutical division offering 950+ high-quality generic products across 30+ therapeutic segments with a robust distribution network for domestic and international markets. Targeted at retail pharmacies, hospitals, and doctors.
• Wellness Division Specialty pharmaceutical division with 900+ products across 32 therapeutic segments, focusing on quality, affordability, and robust distribution.
• Medisciences Division Flagship specialty division for urology and nephrology, offering 15 brands in nephrology and 19 brands in urology, supported by the Reno Academy for doctor and patient support.
• Cosmacia Personal care and wellness division featuring 150+ products with scientifically designed formulas, superspeciality actives, and world-class manufacturing for optimal results.
• Esencia Premium innovative personal care and nutraceutical products division featuring patented actives and quality matching international standards.
• Orthopedic Supports Range of orthosis products including abdominal belts, ankle supports, cervical collars, knee supports, and lumbar sacral belts.
• CAVMOX-625 Tablet Antibiotic tablet for bacterial infections including viral fever complications.
• Debistal-GM 2 Tablets Ayurvedic diabetes management tablet with natural ingredients for holistic diabetes management.
• Calcijoint Suspension Calcium supplement suspension for children's bone health containing Calcium Carbonate and Magnesium Hydroxide.
• Leekuf Tablets Prescription cold and cough relief medication with comprehensive ingredient combination.
• Luliford Cream Antifungal and antibacterial skin cream for treating fungal infections.
• Levocetrizen-5 Anti-allergic medication containing Levocetirizine for allergy relief.

Quantifiable outcome

• 2000+ healthcare, personal care, and nutraceutical products
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Retail PartnerscoreChannel Partner/ Reseller/ DistributorRetail partners stock and sell Leeford pharmaceutical and OTC products. Partners require Drug License, Floor Plan, and GST documentation for enrollment.
• DistributorscoreChannel Partner/ Reseller/ DistributorDistribution partnerships for bulk pharmaceutical product supply across India. Part of robust distribution network with 1800+ touchpoints.
• WholesalerscoreChannel Partner/ Reseller/ DistributorWholesale distribution partnerships for pharmaceutical product supply. Documentation requirements include Drug License and GST registration.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Alkem Laboratories: Indian generic pharma manufacturer with strong domestic brand presence across multiple therapeutic segments. Comparable in product breadth, India-first distribution strategy, and branded generics positioning.
• Glenmark Pharmaceuticals: India-headquartered pharma with branded generics, specialty, and API businesses across emerging markets. Comparable product breadth and emerging-market distribution focus.
• Mankind Pharma: Leading Indian generic pharma manufacturer with similar broad therapeutic coverage and pan-India distribution. Closely comparable in business model (multi-vertical pharma, OTC, consumer health) and domestic market positioning.
• Macleods Pharmaceuticals: Privately-held Indian pharma manufacturer with broad therapeutic coverage and strong domestic distribution. Closely comparable in privately-held status, product breadth, and India-centric model.
• Torrent Pharmaceuticals: Indian-based generic and specialty pharmaceutical company with extensive domestic distribution and growing international footprint. Similar therapeutic breadth and India-centric revenue mix.
• Ajanta Pharma: Indian specialty generics company with branded generics presence in domestic and emerging markets. Comparable therapeutic breadth and specialty-pharma focus, similar mid-cap scale.

Broad incumbents

• Zydus Lifesciences (Cadila): Large Indian pharma group covering generics, biosimilars, consumer wellness, and animal health. Comparable multi-vertical structure (pharma + consumer health) at significantly larger scale.
• Cipla: One of India's largest pharmaceutical companies with a far broader portfolio including respiratory specialty, APIs, and global operations. Comparable therapeutic coverage but much larger scale and international footprint.
• Dr. Reddy's Laboratories: Indian multinational pharma company with significant generics, specialty, and biosimilars operations. Overlaps with Leeford in generic manufacturing but operates at substantially greater scale with deeper global footprint.
• Lupin Pharmaceuticals: Major Indian generic manufacturer with strong domestic franchise and global presence. Comparable in generic-pharma manufacturing focus but materially larger scale and more advanced international regulatory filings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/leefordofficial
• Facebookfacebook.com/leefordhealthcareofficial
• LinkedInlinkedin.com/company/leeford-healthcare-limited

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Leeford